Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk
- PMID: 16251231
- PMCID: PMC1860680
- DOI: 10.1136/hrt.2005.068114
Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk
Abstract
Objective: To determine whether the use of a 20% absolute risk threshold for cardiovascular disease as recommended in current guidelines leads to exclusion of patients with a substantial modifiable risk (> or = 5%).
Methods: Data collected within the framework of a randomised controlled trial in three primary health care centres located in deprived neighbourhoods were analysed. The 10 year absolute risk and the modifiable part of risk were calculated by using the Framingham risk equation. Among patients with a modifiable risk reduction of > or = 5% (number needed to treat < or = 20) the characteristics and risk factors of patients with an absolute risk > or = 20% and those with an absolute risk < 20% were compared.
Results: 293 patients aged 30-70 years at risk of developing cardiovascular disease were included, of whom 66% were women and 36% were of Dutch origin. Of all patients, 33% had an absolute risk > or = 20% and 61% had a modifiable risk > or = 5%. Of those at > or = 20% absolute risk, a vast majority (98%) had a modifiable risk > or = 5%. Among those with an absolute risk < 20%, 43% had a modifiable risk > or = 5%; this group, who were relatively young and predominantly women, constituted 29% of the entire study population.
Conclusions: Targeting preventive strategies at a 10 year absolute risk > or = 20% leads to exclusion of a large group of relatively young, predominantly female patients. In total, about one quarter had an absolute risk < 20% but a modifiable risk > or = 5% and should therefore benefit from intervention.
Conflict of interest statement
Competing interests: none declared.
Similar articles
-
Intensified preventive care to reduce cardiovascular risk in healthcare centres located in deprived neighbourhoods: a randomized controlled trial.Eur J Cardiovasc Prev Rehabil. 2008 Aug;15(4):488-93. doi: 10.1097/HJR.0b013e3282fceac2. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18677177 Clinical Trial.
-
Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.Eur J Prev Cardiol. 2018 Mar;25(4):420-431. doi: 10.1177/2047487317743352. Epub 2017 Nov 24. Eur J Prev Cardiol. 2018. PMID: 29171772 Free PMC article.
-
10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.BMC Pregnancy Childbirth. 2010 Jun 1;10:28. doi: 10.1186/1471-2393-10-28. BMC Pregnancy Childbirth. 2010. PMID: 20515501 Free PMC article.
-
Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.Eur J Prev Cardiol. 2012 Dec;19(6):1365-72. doi: 10.1177/1741826711422979. Epub 2011 Sep 19. Eur J Prev Cardiol. 2012. PMID: 21930719 Clinical Trial.
-
Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases.Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):79-85. doi: 10.1016/j.numecd.2004.12.001. Nutr Metab Cardiovasc Dis. 2005. PMID: 15871855 Review.
Cited by
-
Coping with methodological dilemmas; about establishing the effectiveness of interventions in routine medical practice.BMC Health Serv Res. 2006 Dec 13;6:160. doi: 10.1186/1472-6963-6-160. BMC Health Serv Res. 2006. PMID: 17166255 Free PMC article.
-
Coatings in Decellularized Vascular Scaffolds for the Establishment of a Functional Endothelium: A Scoping Review of Vascular Graft Refinement.Front Cardiovasc Med. 2021 Jul 29;8:677588. doi: 10.3389/fcvm.2021.677588. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34395554 Free PMC article.
-
Different distribution of cardiovascular risk factors according to ethnicity: a study in a high risk population.J Immigr Minor Health. 2008 Dec;10(6):559-65. doi: 10.1007/s10903-008-9144-4. J Immigr Minor Health. 2008. PMID: 18483765
-
Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study.Cardiovasc J Afr. 2008 Mar-Apr;19(2):97-101. Cardiovasc J Afr. 2008. PMID: 18516355 Free PMC article.
References
-
- Blood Pressure Lowering Treatment Trialists' Collaboration Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 20003551955–1964. - PubMed
-
- Critchley J A, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 200329086–97. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources